Maria Luisa Doria
Overview
Explore the profile of Maria Luisa Doria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo F, Doria M, Beliaev A, Kiss L, Bonifacio M, Holenz J, et al.
Xenobiotica
. 2024 Oct;
54(10):796-807.
PMID: 39359020
The metabolism and disposition of zamicastat, a reversible dopamine β-hydroxylase (DβH) inhibitor, developed for treatment of Pulmonary Arterial Hypertension (PAH), were investigated in rats after oral and intravenous administration of...
2.
Dorado E, Doria M, Nagelkerke A, McKenzie J, Maneta-Stavrakaki S, Whittaker T, et al.
J Extracell Vesicles
. 2024 Mar;
13(3):e12419.
PMID: 38443328
Extracellular vesicles (EVs), including exosomes and microvesicles, mediate intercellular communication in cancer, from development to metastasis. EV-based liquid biopsy is a promising strategy for cancer diagnosis as EVs can be...
3.
Dannhorn A, Doria M, McKenzie J, Inglese P, Swales J, Hamm G, et al.
Metabolites
. 2023 Mar;
13(3).
PMID: 36984817
With increased use of mass spectrometry imaging (MSI) in support of pharmaceutical research and development, there are opportunities to develop analytical pipelines that incorporate exploratory high-performance analysis with higher capacity...
4.
Capece D, DAndrea D, Begalli F, Goracci L, Tornatore L, Alexander J, et al.
J Clin Invest
. 2021 Apr;
131(11).
PMID: 33878036
The ability to adapt to low-nutrient microenvironments is essential for tumor cell survival and progression in solid cancers, such as colorectal carcinoma (CRC). Signaling by the NF-κB transcription factor pathway...
5.
Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al.
Cell
. 2020 Jun;
181(7):1596-1611.e27.
PMID: 32559461
Oncogenic transformation is associated with profound changes in cellular metabolism, but whether tracking these can improve disease stratification or influence therapy decision-making is largely unknown. Using the iKnife to sample...
6.
Doria M, McKenzie J, Mroz A, Phelps D, Speller A, Rosini F, et al.
Sci Rep
. 2016 Dec;
6:39219.
PMID: 27976698
Ovarian cancer is highly prevalent among European women, and is the leading cause of gynaecological cancer death. Current histopathological diagnoses of tumour severity are based on interpretation of, for example,...
7.
Archer A, Stolarczyk E, Doria M, Helguero L, Domingues R, Howard J, et al.
J Lipid Res
. 2013 Mar;
54(5):1300-11.
PMID: 23446231
To investigate the role of liver X receptor (LXR) in adipose tissue metabolism during obesity, ob/ob mice were treated for 5 weeks with the synthetic LXR agonist GW3965. MRI analysis...